Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-25T11:55:14.365Z Has data issue: false hasContentIssue false
  • English
  • Français

FC09.05 Clozapine, olanzapine, risperidone, and haloperidol in refractory schizophrenia

Published online by Cambridge University Press:  16 April 2020

P. Mohr ,
J. Volavka ,
J.A. Lieberman ,
P. Czobor ,
J. McEvoy ,
J.-P. Lindenmayer ,
L. Citrome  and
B. Sheitman
P. Mohr
Affiliation:
Charles University Prague & Prague Psychiatric Center, Czech Republic
J. Volavka
Affiliation:
New York University & Nathan Kline Institute
J.A. Lieberman
Affiliation:
University of North Carolina
P. Czobor
Affiliation:
New York University & Nathan Kline Institute
J. McEvoy
Affiliation:
Duke University, USA
J.-P. Lindenmayer
Affiliation:
New York University & Nathan Kline Institute
L. Citrome
Affiliation:
New York University & Nathan Kline Institute
B. Sheitman
Affiliation:
Charles University Prague & Prague Psychiatric Center, Czech Republic University of North Carolina

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Information
European Psychiatry , Volume 15 , Issue S2: Congress of the Association of European Psychiatrists , October 2000 , pp. 284s
Copyright
Copyright © European Psychiatric Association 2000
Submit a response

Comments

No Comments have been published for this article.